BALLAST study: A multicentre, open‐label, randomized‐controlled, 52‐week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine‐enriched amino acid supplementation and physical exercise programme

Documenti analoghi

• The Efficacy of Imeglimin and Metformin on Insulin Sensitivity and Secretion Using Oral Minimal Model: Sub‐Analysis of an Exploratory Randomised Controlled Trial
  di: Ryota Usui, et al.
  Pubblicazione: (2026)
• Endogenous GIP signaling is indispensable for DPP ‐4 inhibitor‐mediated metabolic control in mice
  di: Saki Kubota‐Okamoto, et al.
  Pubblicazione: (2026)
• ChREBP drives β‐cell proliferation under metabolic stress but not in pregnancy‐induced β‐cell expansion
  di: Sodai Kubota, et al.
  Pubblicazione: (2026)
• Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial
  di: Ryota Usui, et al.
  Pubblicazione: (2024)
• Evaluate muscle mass when setting target body weight
  di: Yuji Yamazaki, et al.
  Pubblicazione: (2025)